Treatment Preferences of Adult Patients with Attention-Deficit/Hyperactivity Disorder – A Discrete Choice Experiment
Efficacy was the most important attribute for patients when making treatment decision, but taken together, AEs had greater relative importance than efficacy alone. Accordingly, a profile resembling that of centanafadine would be preferred by an average patient compared to key competitors due to its favorable safety profile. These findings may help improve treatment decision-making, enhance treatment satisfaction, and foster adherence.
Authors
- Jeff Schein (ORCID: https://orcid.org/0009-0006-7892-5005)
- Martin Cloutier (ORCID: https://orcid.org/0000-0002-4867-4739)
- Ann Catherine Childress (ORCID: https://orcid.org/0000-0001-5782-7891)
- Marjolaine Gauthier‐Loiselle (ORCID: https://orcid.org/0000-0002-9439-595X)
- Maryaline Catillon (ORCID: https://orcid.org/0000-0002-1360-8133)
- Beatrice Libchaber
- Yan Meng (ORCID: https://orcid.org/0000-0002-0614-8968)
- Fanny Jiang
Institutions
- Otsuka (United States) (US)
- Center for Psychiatry and Behavioral Medicine (US)
- Institute of Group Analysis (GB)
- Analysis Group (United States) (US)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/ppa.s467724
- Citations
- 4
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 1.54
Funders
- Otsuka Pharmaceutical